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Abstract: The effects of various inhibitors on crude, commercial and partially purified 
commercial mushroom tyrosinase were examined by comparing IC50 values. Kojic acid, 
salicylhydroxamic acid, tropolone, methimazole, and ammonium tetrathiomolybdate had 
relatively similar IC50 values for the crude, commercial and partially purified enzyme.   
4-Hexylresorcinol seemed to have a somewhat higher IC50 value using crude extracts, 
compared to commercial or purified tyrosinase. Some inhibitors (NaCl, esculetin, biphenol, 
phloridzin) showed variations in IC50 values between the enzyme samples. In contrast, 
hydroquinone, lysozyme, Zn
2+, and anisaldehyde showed little or no inhibition in 
concentration ranges reported to be effective inhibitors. Organic solvents (DMSO and 
ethanol) had IC50 values that were similar for some of the tyrosinase samples. Depending 
of the source of tyrosinase and choice of inhibitor, variations in IC50 values were observed. 
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1. Introduction  
 
Tyrosinase (E.C. 1.14.18.1) is a ubiquitous enzyme involved in pigmentation. It catalyzes 
hydroxylation of monophenols (cresolase activity) and oxidation of diphenols (catecholase activity) in 
the presence of molecular oxygen. Enzymes which catalyze the latter reaction are often referred to as 
catechol oxidases and/or polyphenol oxidases (E.C. 1.10.3.1). The distinction between 
polyphenoloxidases and tyrosinases is not always clear because under the right conditions many 
polyphenol oxidases can hydroxylate monophenols [1]. Products formed as a result of tyrosinase 
activity can produce precursors for skin pigmentation, defense and protective mechanisms in plants 
and fungi, and pigments for some flowers [2-6]. On the other hand, products from tyrosinase activity 
can also lead to deleterious effects such as those associated with browning reactions in fruits and 
vegetables and black spotting of shrimp and lobsters [7-8]. 
Commercial mushroom tyrosinase (MT) is often used to screen for anti-browning agents and skin 
whitening agents isolated from natural sources and made synthetically. As such, it serves as an in vitro 
model for the human tyrosinase in the search for decreasing skin pigmentation. Commercial MT 
preparations differ in tyrosinase activity, the presence of carbohydrates, organic material, and other 
proteins and enzymes [9-10]. All of these contaminants have the potential to affect tyrosinase activity 
in vitro, especially with regard to screening compounds for tyrosinase inhibition. Several reports have 
appeared that indicate commercial MT preparations contain laccase [9-12]. Laccase activity can 
interfere with estimations of tyrosinase activity since the enzyme can use many of the same substrates 
as tyrosinase. In addition, laccase contamination in commercial MT preparations, and not tyrosinase, 
was attributed to quinone methide formation [12]. The effects of glycosidase activities in commercial 
MT preparations are just as problematical. For example, esculin, a phenolic glycoside with no 
tyrosinase inhibitory activity, can be converted into esculetin, a phenolic tyrosinase inhibitor, by a 
glucosidase present in commercial MT preparations [9]. Therefore, use of tyrosinase for screening of 
tyrosinase inhibitors may depend on the purity of the enzyme as well as the assay conditions. It has 
been pointed out that MT has different enzymatic and physical properties compared to the human 
enzyme and extrapolation of data using MT may not be transferrable to reactions found in   
humans [13,14]. 
Over the last few years, several hundred tyrosinase inhibitors have been reported. In the majority of 
these examples, commercial MT was used to screen or evaluate these inhibitors. These inhibitors vary 
from simple compounds like NaCl and DMSO to more complex organic compounds isolated from 
natural sources and those compounds synthesized chemically. Reviews of MT and its inhibitors have 
appeared that detail properties of MT and some of the natural and synthetic inhibitors of MT [15-17]. 
Screening for tyrosinase inhibitors has many problems and pitfalls. If a monophenol (i.e., tyrosine) 
is used as a substrate, there is often a lag period when monitoring the enzymatic activity. Steady state 
rates for determining tyrosinase activity may appear after a long time period. Compounds which act as 
inhibitors may extend this lag period and make determination of steady state rates more difficult and 
time consuming. Monitoring oxidation of a diphenol (i.e., DOPA) in the presence of inhibitors is also 
problematical. Steady state rates are often determined from the linear portion of these curves whenever 
possible. The determination of steady state rates can problematical in the presence of tyrosinase 
inhibitors because the absorbance vs. time curve shapes can vary with the concentration of inhibitor Int. J. Mol. Sci. 2009, 10                 
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and the type of inhibitor. This makes estimations of steady state rates more difficult since the linear 
portion of the curve can change in duration and when it is first observable. This also implies that end 
point assays, absorbance measurements at two different time points, may not be reliable indicators of 
steady state rates with regard to MT. 
Because the majority of reports use commercial MT as a source of tyrosinase, we examined 
whether the purity of the enzyme could affect estimations of IC50 values, a parameter often used to 
indicate the potency of a tyrosinase inhibitor. We chose 18 reported tyrosinase inhibitors to test their 
effect on crude, commercial, and purified MT. These inhibitors were chosen based on their availability 
from commercial sources and our own interest in them. 
 
2. Results and Discussion  
 
IC50 values for 18 inhibitors of MT were determined using a crude MT extract, commercial MT, or 
a purified MT sample. Commercial and purified MT isolated from commercial preparations contained 
no latent tyrosinase. Crude extracts of MT appeared to contain latent tyrosinase and assays were 
conducted in the presence of 0.1% SDS to account for latent and active enzyme present (data not 
shown). We arranged these inhibitors into groups based on IC50 value similarities between the different 
tyrosinase samples and to IC50 values for commercial and/or purified MT reported in the literature 
(Table 1 and references therein [18-31]).  
The first group of inhibitors (kojic acid, SHAM, 4 HR, tropolone, methimazole, ATTM) appeared 
to have similar IC50 values for both the commercial and purified MT (Table 1). These IC50 values 
closely resembled or were within ranges to those IC50 values reported in the literature. Using crude 
MT, IC50 values for these inhibitors, with perhaps the exception of 4 HR, were also similar to those 
obtained using commercial or purified MT. 4-Substituted resorcinols, along with tropolone, kojic acid, 
and mimosine referenced therein [32], were reported to be slow binding competitive inhibitors of 
tyrosinase and showed biphasic absorbance vs. time curves. We also observed biphasic absorbance vs. 
time curves for these inhibitors and only used initial rates for determination of their IC50 values. Some 
investigators use end point assays, measuring absorbencies at two different time points for rate 
estimations, to determine IC50 values for tyrosinase inhibitors. For slow binding inhibitors, and other 
compounds not yet identified as slow binding inhibitors, use of end point assays may lead to   
IC50 values that are not similar to that those measured under initial rate conditions or constant rate 
conditions. Park et al. [23] reported inhibition of tyrosinase by ATTM. Their absorbance vs. time 
curves also showed a biphasic response, which suggests this compound may also be a slow binding 
inhibitor. We also observed these biphasic curves and inhibition by ATTM below 10-20 μM. 
However, at higher concentrations of ATTM we observed absorbance vs. time curves that showed an 
initial decrease in absorbance that eventually “leveled out” and later began a gradual increase in 
absorbance depending on the concentration of ATTM. Thus, it was difficult to determine rates at 
greater than 10 μM ATTM.  
 Int. J. Mol. Sci. 2009, 10                 
 
 
3814
Table 1. IC50 values for mushroom tyrosinase inhibitors. 
Inhibitor 
Crude MT  Commer. MT  Purified MT  Reported IC50 Values 
µM µM  µM µM 
kojic acid  36  47  45  10-300 [10,18] 
SHAM  0.24  0.4  0.45  0.45 [19], 0.8, 1.2 [10] 
4-HR  5.8  1.5  1.2  0.85 [20], 2.5, 18 [10] 
tropolone  0.39  1.2  0.95  0.4 [21], 1.3, 1.7 [10] 
methimazole  46  55  50  200 [22], 40, 47 [10] 
ATTM  3.4  3.3  2  2 [23], 7.5, 28 [10] 
        
NaCl  65 mM  270 mM  360 mM  25 mM [24] 
esculetin
*  70  280  685  43 [25], 210, 225 [10] 
biphenol
*  50
a 10
b  67
c  1.9 (tyrosine) [26] 
phloridzin
* 625  1740  1400  110  [27] 
        
hydroquinone activates
d  activates
e  activates
f  26 [18] 
lysozyme >10  mg/mL
g  >20 mg/mL
h  >20 mg/mL
i  0.32 µM [28] 
ZnSO4  none@1 mM  none@1 mM  none@1 mM  50 [29] 
anisaldehyde
*  1 mM  1.4 mM  1.8 mM
j  160 [30] 
        
DMSO  2 M  1.75 M  1.4 M  2.45 M [31] 
dimethyl sulfide  NI to 500 µM  NI to 500 µM  NI to 500 µM   
dimethyl sulfone  NI to 2 mM  NI to 2 mM  NI to 2 mM   
ethanol  2.3 M  2.1 M  1.8 M   
        
Assays were carried out as described in the experimental section. a) 50% inhibition at 50 µM, no 
decrease in activity beyond 100 µM ; b) 50% inhibition at 10 µM, increases in activity beyond  
10 µM; c) 50% inhibition at 67 µM, increases in activity beyond 100 µM; d) activated up to  
100 µM, 50% inhibition at 800 µM; e) activated up to 400 µM ; f) activated up to 500 µM; g) 25% 
inhibition at 10 mg/mL; h) 18% inhibition at 20 mg/mL; i) 8% inhibition at 20 mg/mL; j) 50% 
inhibition at 1.8 mM, remained at 60% from 2-5 mM; * - indicates compounds dissolved in DMSO; 
NI-no inhibition. 
 
Many investigators use kojic acid as a reference inhibitor, and it is surprising that IC50 values for 
kojic acid vary over such a wide range (Table 1, [18]). Our IC50 values are within the lower end of 
these ranges. Figure 1 shows a plot of MT activity vs. kojic acid concentration for commercial and 
purified MT used to determine an IC50 value. We show these two curves because most IC50 values are 
reported using the commercial MT and sometimes using a purified MT. Even though the commercial 
and purified tyrosinase showed different enzyme activity in the absence of kojic acid, the IC50 values 
and inhibition curves were similar. In general, for inhibitors in group 1 it appears that the purity of 
tyrosinase does not have a significant effect on IC50 values.  Int. J. Mol. Sci. 2009, 10                 
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Figure 1. Inhibition of mushroom tyrosinase by kojic acid. Assays were carried out as 
described in the Experimental section. 
 
 
The second group of inhibitors (NaCl, esculetin, biphenol, phloridzin) seemed to show a few 
differences in IC50 values between the crude, commercial and purified enzyme (Table 1). For the most 
part, this group of inhibitors also appeared to have much larger IC50 values than those reported in 
Table 1. For example, NaCl and esculetin seemed to show an increase in IC50 values from crude to 
commercial to purified MT. In contrast, biphenol did not show quite as large a variation in IC50 values 
among the tyrosinase samples, although the IC50 for biphenol was much smaller for commercial MT. 
Except for phloridzin, the IC50 values for NaCl, esculetin and biphenol seemed to be larger for the 
purified enzyme compared to the commercial or crude enzyme in this group of inhibitors.  
Figure 2 shows the plot of MT activity vs. NaCl concentration using the commercial and purified 
MT. These IC50 v a l u e s  f o r  N a C l  w e r e  m u c h  h i gher than that reported by Park et al. [24], who 
suggested that Cl
- was responsible for inhibition and not Na
+. They also used DOPA as a substrate for 
tyrosinase. We have no reasonable explanation for the difference in our results vs. those by Park et al. 
[24] except for the source of commercial tyrosinase used in the two studies. However, even our 
purified MT showed a much higher IC50 value than the commercial MT. 
Figure 3 shows a plot of activity of MT vs. esculetin concentration for commercial and purified MT. 
IC50 values for esculetin were much higher than that reported by Masamoto [25], although Flurkey  
et al. [10] did report a comparable IC50 value for esculetin using commercial MT. Even though 
esculetin has been reported to be an inhibitor, Munoz-Munoz et al. [33] have shown that esculetin can 
be used as an alternative substrate for MT and peroxidase using a chronometric assay. Sollai et al. [34] 
has also shown that esculetin can be oxidized by MT, plant polyphenol oxidases, and laccase although 
at slow rates. Thus, apparent inhibition by esculetin could be explained by competition for two 
different substrates. However, it is still hard to reconcile the differences in IC50 values between the MT 
samples we tested, especially the 685 µM IC50 value for purified MT. Int. J. Mol. Sci. 2009, 10                 
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Figure 2. Inhibition of mushroom tyrosinase by NaCl. Assays were carried out as 
described in the Experimental section. 
 
Figure 3. Inhibition of mushroom tyrosinase by esculetin. Assays were carried out as 
described in the Experimental section. 
 
 
Kim et al. [26] obtained an IC50 value for biphenol of approximately 2 μM using tyrosine as a 
substrate instead of DOPA, although they monitored dopachrome formation from tyrosine. Using 
DOPA as a substrate, we observed a large variation in IC50 values for biphenol between crude and 
purified MT vs. commercial MT. In addition, we observed increases in tyrosinase activity at 
concentrations above 20 μM for commercial MT and 100 μM biphenol for purified MT (data not 
shown). Using crude tyrosinase extracts, there was a 50% decrease in enzyme activity from 0 to 50 μM 
biphenol but no further inhibition was observed up to 500 μM biphenol (data not shown).  
In general, it was difficult to discern a consistent pattern in IC50 values in group 2 with regard to the 
purity of tyrosinase. It is possible that some of these inhibitors could be affected by material in crude Int. J. Mol. Sci. 2009, 10                 
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extracts and in commercial samples of MT differently or behaved differently with a more purified 
source of enzyme. 
The third group of inhibitors (hydroquinone, lysozyme, ZnSO4, anisaldehyde) tested seemed to 
show little or no inhibition of tyrosinase or required concentrations to reach 50% inhibition that were 
much different than those reported by other investigators (Table 1). This was true for all of the 
different tyrosinase samples tested. For example, using DOPA as a substrate we found that 
hydroquinone increased reactions rates at lower concentrations of hydroquinone and caused inhibition 
at higher concentrations for some of the enzyme samples (Figure 4). Although hydroquinone has been 
reported to be an inhibitor of MT, Kasraee [35] and Passi and Nazzaro-Porro [36] have reported that 
hydroquinone can act as a substrate for MT in which the oxidation product of hydroquinone, 
parabenzoquinone, can oxidize DOPA. Enhancement in our observed rates at lower concentrations of 
hydroquinone could be a result of hydroquinone coupled oxidation of DOPA as well as enzyme 
catalyzed oxidation of DOPA. This apparent activation varied between 20-500 μM hydroquinone for 
the different MT samples (Figure 4). The crude tyrosinase showed a decrease in activity beyond   
100 µM hydroquinone, while the commercial enzyme showed increased activity up to 400 µM 
hydroquinone. In contrast, the purified enzyme showed an increase in activity with increasing 
hydroquinone up to 200 µM and then activity seemed to remain relatively constant up to 500 µM 
hydroquinone. 
 
Figure 4. Inhibition of mushroom tyrosinase by hydroquinone. Assays were carried out as 
described in the Experimental section. 
 
For lysozyme, we could not add enough inhibitor into the assay to determine an IC50 value and 
observed less than 50% inhibition, even with 10-20 mg/mL (700-1,400 µM) lysozyme in the assay. 
This is in contrast to Li et al. [28], who found that lysozyme inhibited MT with an IC50 value of  
0.32 µM (4.6 µg/mL). They also suggested that inhibition was dependent upon the time of   
pre-incubation of lysozyme with tyrosinase. For example, Li et al. [28] observed 8% inhibition on 
mixing MT with lysozyme just before assaying but found 30% inhibition if MT and lysozyme were Int. J. Mol. Sci. 2009, 10                 
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incubated for one hour before assaying. We found 8-25% inhibition when large amounts of lysozyme 
(10-20 mg/mL) were mixed with MT just before assaying, but did not attempt to incubate MT and 
lysozyme for various times to increase the percent inhibition. We also tried three different sources of 
lysozyme with the similar results (data not shown).  
Effects of Zn
2+ and anisaldehyde on mushroom tyrosinase were examined. In monitoring the 
oxidation of DOPA to dopachrome, we found no inhibition of MT by Zn
2+, even at concentrations up 
to 1 mM (Table 1). This is in contrast to that reported by Han et al. [29]. However, they used a much 
different assay for tyrosinase that coupled DOPA oxidation to a change in the coloration of thymol 
blue as a result of protonation. Since our assays monitor DOPA oxidation directly, we can only 
surmise that Zn
2+ may cause some sort of interference in the coupled assay reported by Han et al. [29]. 
We were able to determine IC50 values for anisaldehyde using the crude, commercial and purified MT  
(Table 1). These values ranged from 1 to 1.8 mM between the mushroom samples but were much 
larger that that reported by Ha et al. [30]. Although we did not check for the presence of anisic acid in 
the anisaldehyde, anisic acid has been shown to be a MT inhibitor with an IC50 value of 680 µM [37]. 
In general, the IC50 values in this third group of inhibitors were much different than that reported by 
citations listed in Table 1 even though the crude, commercial and purified MT appeared to behave in a 
similar manner with these inhibitors. 
The fourth group of potential MT inhibitors (DMSO, dimethyl sulfide, dimethyl sulfone, ethanol) 
comprised compounds that are commonly used to dissolve MT inhibitors and/or may be potential 
contaminants in DMSO preparations (Table 1). IC50 values for ethanol were similar for all MT 
samples tested. Little to no inhibition was observed for dimethyl sulfide up to 500 μM using any of the 
MT samples tested. Perez-Gilabert and Garcia-Carmona reported that dimethyl sulfide is a slow 
binding inhibitor of tyrosinase, although they did not report IC50 values [38]. We also observed 
relatively little inhibition of tyrosinase up to 2 mM dimethyl sulfone.  
Inhibition by DMSO did not appear to be much different for crude or commercial MT even though 
the IC50 values were larger that using the purified MT. Our IC50 values for DMSO using commercial 
and purified MT were somewhat lower than that reported by Chen et al. [31]. We did find that 
inhibition by DMSO might be dependent on the source and/ or purity of the DMSO used (data not 
shown). We also observed that high concentrations of DMSO caused a precipitate to form in the assay 
solution, presumably inorganic compounds that are less soluble as the DMSO increased in 
concentration. DMSO has also been shown to cause protein precipitation and denaturation by Arakawa 
et al. [39] at higher DMSO concentrations. In addition, Tjernberg et al. [40] reported that even low 
concentrations of DMSO (< 5 %) can destabilize proteins. These effects may have to be considered 
when examining inhibitory effects of organic solvents or inhibitors dissolved in organic solvents, like 
DMSO, on tyrosinase activity. In general, and with the exception of DMSO, the fourth group of 
potential tyrosinase inhibitors displayed similar IC50 values for the different sources of tyrosinase. Int. J. Mol. Sci. 2009, 10                 
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3. Experimental Section  
 
3.1. Materials 
 
Commercial mushroom tyrosinase was purchased from Worthington Biochemical Corp. 
(Lakewood, NJ, USA). Substrates and inhibitors were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). Anisaldehyde was obtained form J.T. Baker Chemical Co. (Phillipsburg, NJ, USA). Dimethyl 
sulfoxide (DMSO) was reagent grade from Sigma-Aldrich (St. Louis, MO, USA). 
 
3.2. Methods 
 
3.2.1. Crude Extract Tyrosinase Preparation  
 
White button mushrooms were purchased from local stores and blended in 100 mM sodium 
phosphate (pH 6.0) containing 1 mM EDTA, 1 mM PMSF, 5 mM ascorbic acid  and 1 M sucrose. The 
homogenates were filtered and stored at -15 C in small aliquots. Commercial mushroom tyrosinase. 
Mushroom tyrosinase was dissolved in the above buffer without ascorbic acid at 2 mg dry weight/mL 
and stored at 5 C in small aliquots. 
 
3.2.2. Enzyme Purification  
 
Tyrosinase was partially purified from commercial mushroom tyrosinase preparations using 
ammonium sulfate precipitation (35-60%), ion exchange on DEAE Sepharose CL-6B, hydrophobic 
interaction on Phenyl Sepharose in 1 M NaCl, and adsorption on hydroxyapatite [41,42]. 
 
3.2.3. Enzyme Assays  
 
Each one mL assay contained a final concentration of 100 mM sodium phosphate (pH 6.5) and  
2 mM DOPA. Crude, commercial or partially purified tyrosinase was added to initiate the reaction. 
Oxidation of DOPA into dopachrome was monitored at 475 nm. One unit of activity was defined as  
1 µmole dopachrome formed per min per ml enzyme using an extinction coefficient of 3600 M
-1 cm
-1. 
Rates were determined from the linear portion of the absorbance vs. time curves. Crude enzyme was 
use at a concentration of 0.1 units (8.4 µg protein) per mL in the assay and assayed in the presence of 
0.1% SDS. Commercial tyrosinase was used at a concentration of 0.038 units (3.3 μg protein) per mL 
in the assay. The purified enzyme was used at a concentration of 0.0067 units (0.58 μg protein) per mL 
in the assay.  
 
3.2.4. IC50 Determinations  
 
Various amounts of inhibitors were added into assays to determine a range of inhibitors needed to 
encompass the IC50 value. Then assays were repeated within this range of inhibitor concentrations. 
Rates were determined as above. If any inhibitor caused a significant change in the shape of the A vs. Int. J. Mol. Sci. 2009, 10                 
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time curve, rates were calculated from steady state rate regions (linear portions) in the curves. The 
concentration of inhibitor needed to inhibit 50% of the tyrosinase activity was extrapolated from % 
activity vs. [inhibitor] curves. For some inhibitors, we also used Statistical Data Analysis Software 
(SDAS, version 2008A) using an exponential equation to obtain a best fit curve and then to calculate 
IC50 values. For the crude and commercial MT, experiments were repeated at least twice and the 
average IC50 value reported. Because of the limited amount of purified tyrosinase, not all experiments 
could be repeated twice. In experiments requiring DMSO to dissolve the inhibitor, control assays 
contained the assay mixture with DMSO but minus inhibitor. Final DMSO concentrations were 5% or 
less in the assays. 
 
4. Conclusions  
  
IC50 values for tyrosinase inhibitors can vary for a number of reasons, including choice of assay 
conditions, rate determinations, and solvent considerations. Therefore, it is sometimes difficult to 
reproduce data reported in the literature. Our results seem to indicate the IC50 values can also vary 
depending on the purity of the tyrosinase. However, this observation also seems to be related to the 
type of inhibitor used. Crude MT extracts and commercial MT sources contain a variety of proteins, 
enzymes, carbohydrate, and organic compounds. Any one of these substances can interfere with IC50 
value estimations through chemical or enzymatic reactions. We suggest that MT preparations need to 
be partially purified to eliminate these potential problems in IC50 value determinations.  
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